sub:assertion {
drugbank:DB00962 a biolink:Drug ;
rdfs:label "Zaleplon" ;
biolink:category biolink:Drug .
mondo:0100081 a biolink:Disease ;
rdfs:label "sleep disorder" ;
biolink:category biolink:Disease .
sub:association rdf:object mondo:0100081 ;
rdf:predicate biolink:treats ;
rdf:subject drugbank:DB00962 ;
a biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation ;
rdfs:label "Melatonin (97%), trazodone (81%), and quetiapine (73%) were rated by a majority of respondents as effective. Doxepin, zaleplon, tricyclic antidepressants, zolpidem, or lorazepam were rarely prescribed due to lack of evidence and/or concerns about adverse effects, long-term safety, suitability for youth, suicidality, and dependence/tolerance." ;
biolink:aggregator_knowledge_source infores:knowledge-collaboratory ;
biolink:category biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation ;
biolink:has_population_context sub:context ;
biolink:publications pmid:32175006 ;
biolink:relation ncit:C94303 .
sub:context a biolink:Cohort ;
rdfs:label "Children and adolescents" ;
biolink:category biolink:Cohort ;
biolink:has_phenotype mondo:0005371 .
}